Why Is CRISPR Therapeutics AG (NASDAQ: CRSP) Stock Down Today?

CRISPR Therapeutics AG (NASDAQ: CRSP) Summary

CRISPR Therapeutics AG (NASDAQ: CRSP) is trading down -1.20% at $49.39, reflecting a negative shift in investor sentiment today. The stock opened at $49.31 and has moved between $48.02 and $49.68 so far.

Trading volume is 1924713, which is 24% above its average, and the price action suggests selling interest.

Technically, CRSP on the NASDAQ is trading below its 50-day moving average of $54.65 and below its 200-day moving average of $53.02, indicating short-term and long-term weakness.

Analyst sentiment is bullish. Meyka's AI assigns CRSP a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of -45.66% in 1 month ($26.84), -2.83% in 1 year ($47.99), and -16.03% in 5 years ($41.47).

See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NASDAQ.
Stay informed and make better investment decisions.